Xinxuan Li

机构：Peking University, Beijing National Laboratory for Molecular Sciences, China Huadian Corporation (China), Second Affiliated Hospital of Zhejiang University, Zhejiang University · ORCID：0000-0001-8922-661X

发表论文 42 篇 · 总被引 509 次 · h-index 12

代表论文

• Dietary patterns in the progression of metabolic dysfunction-associated fatty liver disease to advanced liver disease: a prospective cohort study (2024 · American Journal of Clinical Nutrition · 被引 20)
• Inhibition of intrarenal PRR-RAS pathway by Ganoderma lucidum polysaccharide peptides in proteinuric nephropathy (2023 · International Journal of Biological Macromolecules · 被引 20)
• Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer (2024 · JNCI Journal of the National Cancer Institute · 被引 19)
• Synthesis of chiral allylic phosphonates via asymmetric reductive cross-coupling of α-bromophosphonates and vinyl bromides (2023 · Science China Chemistry · 被引 16)
• Transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption (2024 · Acta Pharmaceutica Sinica B · 被引 13)
• Optical controlled and nuclear targeted CECR2 competitor to downregulate CSF-1 for metastatic breast cancer immunotherapy (2024 · Biomaterials · 被引 12)